Jazz Pharmaceuticals plc: Bernstein cuts target price to $220 from $229
JAZZ•Bernstein cut its target price for Jazz Pharmaceuticals to $220 from $229.
Related News
Barrick Q3 net earnings rise year-over-year to USD 1.32 billion; revenue climbs 22% to USD 5.07 billion
B•
Barrick Mining Q3 revenue rises 22% on higher gold prices
B•
South African FLAC demand weakens as issuance strains investor capacity, Futuregrowth says
TLT•
Citigroup raises European food and beverage sector to overweight from neutral
XLP•
QXO Q3 revenue beats analyst estimates, helped by Kodiak and acquisitions
QXO•